LUMIOS - A Phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group trial to assess the efficacy, safety and tolerability of cenerimod in adult patients with systemic lupus erythematosus and active lupus nephritis in combination with background therapy
Lupus is an autoimmune condition where the body's immune system attacks healthy tissue. In some people, this causes lupus nephritis, leading to inflammation and damage in the kidneys. The LUMIOS trial is testing a study medicine called cenerimod to find out if it is safe and effective when added to standard lupus treatments. Adults aged 18 and over who have active lupus nephritis can take part. Half of the participants will receive cenerimod, and half will receive a dummy pill (placebo), alongside their usual medications. The trial lasts around 76 weeks (about a year and a half). Doctors will check kidney health through regular urine and blood tests. They hope cenerimod will reduce kidney inflammation, prevent long-term damage, and allow people to lower their daily dose of steroids.
At a glance
What is this study about?
Systemic lupus erythematosus, often called lupus, is an autoimmune condition. This means your immune system, which usually fights off infections, gets confused and attacks healthy parts of your body. When lupus affects the kidneys, it is called lupus nephritis. The kidneys are vital because they filter waste and extra water from your blood. Kidney inflammation can cause protein to leak into your urine and may lead to lasting kidney damage if not controlled.
Current treatments often include strong medicines like steroids. While these drugs can help calm the immune system, taking them at high doses for a long time can cause unpleasant side effects. Researchers are looking for newer, targeted treatments that can help protect the kidneys while allowing people to safely take lower doses of steroids.
The LUMIOS study is looking at a new medicine called cenerimod. Doctors want to see if taking cenerimod alongside regular lupus medicines works better than regular medicines alone. By measuring kidney function and checking the levels of protein in the urine over 76 weeks, the study aims to find out if cenerimod can help kidneys heal and stay healthy.
Key takeaways
- The trial tests a new drug called cenerimod for adults with active lupus kidney inflammation.
- The goal is to protect kidney function and reduce protein leakage in the urine.
- Researchers hope it will help patients safely lower their daily steroid medication.
- Participation lasts about 76 weeks and involves regular clinic visits and tests.
- Taking part is voluntary, and you can leave the study at any time.
Who may be eligible?
This study is open to adults aged 18 and older who have been diagnosed with systemic lupus erythematosus and have active lupus nephritis. Both men and women can join.
To take part, you must have active kidney inflammation caused by your lupus. This is usually shown by protein in your urine and specific blood test results. You must also be receiving standard background treatment for your condition.
Not everyone will be able to take part. People with certain other severe medical problems, very advanced kidney failure, or specific ongoing infections may not be able to join. The study doctor will review your complete medical history and carry out health checks to see if the trial is safe and suitable for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I have been diagnosed with systemic lupus erythematosus (lupus).
- I have active kidney inflammation (lupus nephritis).
- I am currently taking standard treatment for my lupus.
- I am able to attend regular hospital appointments for about 76 weeks.
What does participation involve?
Taking part in this study lasts for at least 76 weeks, which is about a year and a half. During this time, you will take either the study medicine (cenerimod) or an inactive dummy pill (placebo) once daily. Neither you nor your doctor will know which one you are receiving. You will continue to take your regular background lupus medicines as directed.
You will need to attend regular clinic appointments at a hospital or trial centre. At these visits, the medical team will check your blood pressure, test your blood and urine to monitor your kidney function, and ask about any symptoms or side effects. The team will also monitor how much steroid medicine you need to manage your lupus. You can leave the study at any point if you change your mind.
Potential risks and benefits
Locations (5)
- —UnverifiedGermany
- —UnverifiedSpain
- —UnverifiedPoland
- —UnverifiedBulgaria
- —UnverifiedRomania
Common questions
What is a placebo?
A placebo is a dummy pill that looks identical to the real medicine but contains no active ingredients. It helps researchers prove whether the real medicine actually works.
Can I keep taking my regular lupus medications?
Yes. This trial tests cenerimod added to your standard background lupus treatment, so you will continue to receive care for your condition.
How will doctors check if the medicine is working?
Doctors will test your urine for protein levels and check your blood to see how well your kidneys are filtering waste over the 76 weeks.
Do I have to pay to take part in this trial?
No, all study medicines, tests, and trial-related doctor visits are provided free of charge, and travel expenses are often reimbursed.
What happens if I want to leave the study early?
You are free to leave the trial at any time. Your normal NHS care and relationship with your doctors will not be affected in any way.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.